Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer.
Yang X, Ma X, Zhao T, Croucher DR, Nguyen EV, Clark KC, Hu C, Latham SL, Bayly-Jones C, Nguyen BV, Budnar S, Shin SY, Nguyen LK, Cotton TR, Chüeh AC, Lim Kam Sian TCC, Stratton MM, Ellisdon AM, Daly RJ.
Yang X, et al.
Nat Commun. 2025 Feb 22;16(1):1871. doi: 10.1038/s41467-025-57046-8.
Nat Commun. 2025.
PMID: 39984440
Free PMC article.